COX-2 and angiogenesis in gastric cancer

Journal of Clinical Gastroenterology

Volumn 37, Issue 1, 2003, Pages 4-6

  Walther, Zenta ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT;

ANGIOGENESIS; CANCER GROWTH; CARCINOGENESIS; DISEASE ASSOCIATION; EDITORIAL; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LYMPHOKINES; MEMBRANE PROTEINS; MICE; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038274684     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200307000-00003     Document Type: Editorial

References (33)

1. Williams CS, Mann M. DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999;18:7908-7916.
2. Thun MJ. Namboodiri MM, Heath CWJ. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991;325:1593-1596.
3. Thun MJ, Namboodiri MM, Calle EE, et al. Aspirin use and risk of fatal cancer. Cancer Res. 1993;53:1322-1327.
4. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindae in familial adenomatous polyposis. N Engt J Med. 1993;328:1313-1316.
5. Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2). Cell. 1996;87:803-809.
6. Seno H, Oshima M, Ishikawa TO. et al. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res. 2002;62:506-511.
7. Dormond O, Ruegg C. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives. Drug Resist Updat. 2001;4:314-321.
8. Fosslien E. Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci. 2001;31:325-348.
9. Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells. Cell. 1998;93:705-716.
10. Sawaoka H, Tsuji S, Tsujii M, et al. Cyclooxygenase inhibitors suppress angio-genesis and reduce tumor growth in vivo. Lab Invest. 1999;79:1469-477.
11. Daniel TO, Liu H, Morrow JD, et al. Thromboxane A2 is a mediator of cyclo-oxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 1999;59:4574-4577.
12. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29:15-18.
13. Hasan J, Byers R, Jayson GC. Intra-tumoural microvessel density in human solid tumours. Br J Cancer. 2002;86:1566-1577.
14. Cianchi F, Cortesini C, Bechi P. et al. Up-regulation of Cyclooxygenase 2 Gene Expression Correlates With Tumor Angiogenesis in Human Colorectal Cancer. Gastro. 2001;121:1339-1347.
15. Masunaga R, Kohno H. Dhar DK. et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res. 2000;6:4064-4068.
16. Uefuji K, lchikura T. Mochizuki H. Cyclooxygenase-2 Expression Is Related to Prostaglandin Biosynthesis and Angiogenesis in Human Gastric Cancer. Clin Cancer Res. 2000;6:135-138.
17. Rahman MA, Dhar DK, Yamaguchi E, et al. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res. 2001;7:1325-1332.
18. Fujiwaki R, Iida K, Kanasaki H, et al. Cyclooxygenase-2 Expression in Endometrial Cancer: Correlation With Microvessel Count and Expression of Vascular Endothelial Growth Factor and Thymidine Phosphorylase. Hum Pathol. 2002;33:213-219.
19. Costa C, Soares R, Reis-Filho JS, et al. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol. 2002;55:429-434.
20. Kirkpatrick K, Ogunkolade W, Elkak A, et al. The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. Curr Med Res Opin. 2002;18:237-241.
21. Gallo O, Franchi A, Magnelli L, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia. 2001;3:53-61.
22. Gallo O, Masini E, Bianchi B, et al. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol. 2002;33:708-714.
23. Joo YE, Rew JS, Seo YH, et al. Cyclooxygenase-2 Overexpression Correlates with Vascular Endothelial Growth Factor Expression and Tumor Angiogenesis in Gastric Cancer. J Clin Gastro. Current issue.
24. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 1996;32:2474-2484.
25. Ohno R, Yoshinaga K, Fujita T, et al. Depth of Invasion Parallels Increased Cyclooxygenase-2 Levels in Patients with Gastric Carcinoma. Cancer. 2001;91:1876-1881.
26. Lim HY, Joo HJ, Choi JH, et al. Increased Expression of Cyclooxygenase-2 Protein in Human Gastric Carcinoma. Clin Cancer Res. 2000;6:519-525.
27. Murata H, Kawano S, Tsuji S, et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol. 1999;94:451-455.
28. Ristimaki A, Honkanen N, Jankala H, et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 1997;57:1276-1280.
29. Yamagata R, Shimoyama T, Fukuda S, et al. Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. Eur J Gastroenterol Hepatol. 2002;14:359-363.
30. Hahm KB, Song YJ, Oh TY, et al. Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? J Biochem Mol Biol. 2003;36:82-94.
31. Walker MM. Cyclooxygenase-2 expression in early gastric cancer, intestinal metaplasia and Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2002;14:347-349.
32. Dang CT, Shapiro CL, Hudis CA. Potential role of selective COX-2 inhibitors in cancer management. Oncology. 2002;16:30-36.
33. Blanke CD. Celecoxib with chemotherapy in colorectal cancer. Oncology. 2002;16:17-21.